Mersana Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States51-200 Employees
Mersana Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on developing antibody-drug conjugates for cancer. It operates on proprietary platforms for cytotoxic and immunostimulatory ADCs, named Dolasynthen and Immunosynthen, to build a pipeline of wholly-owned and partnered product candidates. Its programs include XMT-1660, a Dolasynthen ADC targeting B7-H4, and XMT-2056, an Immunosynthen ADC targeting a novel epitope of HER2, reflecting a strategy to address cancer with targeted therapies. The company works within the biotechnology research sector and positions itself as a clinical-stage developer aiming to treat cancers with high unmet medical need. In 2025, press reports indicated that Day One Biopharmaceuticals planned to acquire Mersana, signaling a notable corporate development for the firm.